BXN 13.3% 1.7¢ bioxyne limited

Obviously Mymana progress has continued but encountered delays...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,410 Posts.
    lightbulb Created with Sketch. 131
    Obviously Mymana progress has continued but encountered delays launching into China. Perhaps this will change very soon.

    26 February 2018

    https://smallcaps.com.au/bioxyne-colostrum-honey-health-product-chinese-market/

    Biotech company Bioxyne Limited (ASX: BXN)has revealed it is working on plans to cast its novel New Zealand honey product into China, thereby capturing an overlooked portion of the nutritional consumer market that’s growing rapidly on the back of a thriving middle-class in southeast Asia and China in particular.

    MYMANA is a unique formulation of colostrum, honey and dairy milk formula, sourced from New Zealand and “boosted with vitamins and minerals for sustained energy,” according to Bioxyne.

    BXN are not limited to only the above.
 
watchlist Created with Sketch. Add BXN (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
0.002(13.3%)
Mkt cap ! $26.60M
Open High Low Value Volume
1.6¢ 1.8¢ 1.6¢ $23.22K 1.367M

Buyers (Bids)

No. Vol. Price($)
2 588235 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 316000 2
View Market Depth
Last trade - 15.52pm 02/12/2024 (20 minute delay) ?
BXN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.